Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial.

J Clin Oncol · 2021 · PMC8677956 · PMID 34597119

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Unlike castration-resistant Pca, the AR-V7 variant has been found in naïve patients with SDC, 29 with a nonsignificant trend toward female over male patients, 30 and six female patients were included in the enzalutamide trial compared with one female in our study.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.